Stanley T. Crooke, Chairman and CEO at IONIS PHARMACEUTICALS INC (IONS), sold 23,924 shares at $44.50 ($1.1M) on 2018-04-17, disclosed to the SEC on 2018-04-19.
Open-market sale of $1.1M IONS by Chairman and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.30 | 2,000 | $89K | 8.3% |
| 2 | $44.30 | 4,981 | $221K | 20.8% |
| 3 | $44.30 | 4,981 | $221K | 20.8% |
| 4 | $44.50 | 2,000 | $89K | 8.4% |
| 5 | $44.50 | 4,981 | $222K | 20.9% |
| 6 | $44.50 | 4,981 |
| $222K |
| 20.9% |
| Total | $44.40 avg | 23,924 | $1.1M | 100% |
| Filing → |
| IONS | SELL | 2020-12-17 | $2.1M | — | Filing → |
| IONS | SELL | 2020-12-09 | $568K | — | Filing → |
| IONS | SELL | 2020-11-30 | $1.3M | — | Filing → |